Two genes important for human development and implicated in cancer and schizophrenia also help keep a healthy balance between excitation and inhibition of brain cells, researchers say.
Community preparedness for a bioterrorism attack or influenza outbreak has been the focus of much interest and effort in recent years.
Veterans exposed to Agent Orange have a 48 percent increased risk of prostate cancer recurrence following surgery than their unexposed peers, and when the disease comes back, it seems more aggressive, researchers say.
Scientists have found evidence that the cox-2 inhibitor celecoxib, a common pain reliever used to treat arthritis, may offer a new way to reduce the risk of the most common cause of brain damage in babies born prematurely.
A Web-based program that provides prostate cancer patients with information about different treatment approaches may make deciding which path to follow a little easier, Medical College of Georgia researchers say.
Weill Cornell Medical College researchers are using a virtual reality simulation called “Virtual Iraq” to better understand how symptoms of post-traumatic stress disorder (PTSD) develop.
Medical research scientists in public health and other areas routinely make ethical value judgments, even if they’re not aware of it, according to a new Weill Cornell Medical College research study. And not only do these judgments not lead to bias necessarily, but they can make for better research.
While drug-eluting stents are effective in keeping open diseased heart arteries, they should not be used for patients who need to have noncardiac surgery a short time after an interventional heart procedure. A presentation at the Society for Cardiovascular Angiography and Interventions in Orlando by cardiologists at Jefferson Medical College indicates that for these patients, bare metal stents provide a safer choice.
Yale Cancer Center physicians have presented clinical recommendations for the diagnosis and subsequent treatment of superior vena cava syndrome in this week?s issue of the New England Journal of Medicine.
Hamilton College researchers have identified molecules that have been shown to be effective in the fight against breast cancer.